Related Experiment Video
Updated: Nov 4, 2025

10:47
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
9.0K
A simple and feasible atom-precise biotinylated Cu(i) complex for tumor-targeted chemodynamic therapy
Bi Luo1, Liguang Chen, Zhaoguo Hong
1State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, P. R. China. huangfp2010@163.com liangzhang319@163.com.
Summary
Researchers developed a biotinylated copper complex for tumor-targeted chemodynamic therapy. This agent uses hydrogen peroxide (H2O2) in tumors to generate hydroxyl radicals (•OH) for cancer treatment.
Area of Science:
- Biomedical Engineering
- Materials Science
- Oncology
Background:
- The tumor microenvironment often overexpresses hydrogen peroxide (H2O2).
- Chemodynamic therapy (CDT) offers a promising approach for cancer treatment.
- Targeted delivery of therapeutic agents is crucial for effective cancer therapy.
Purpose of the Study:
- To synthesize and characterize a novel atom-precise biotinylated Cu(i) complex.
- To investigate the catalytic activity of the complex in generating hydroxyl radicals (•OH) via Fenton-like reactions.
- To evaluate the efficacy of the complex as a tumor-targeted agent for chemodynamic therapy.
Main Methods:
- Synthesis of an atom-precise biotinylated Cu(i) complex.
- Characterization of the complex's structure and properties.
- In vitro assessment of the complex's catalytic activity in producing •OH in the presence of H2O2.
- Evaluation of tumor-targeting ability and therapeutic efficacy in relevant models.
Main Results:
- A simple and feasible atom-precise biotinylated Cu(i) complex was successfully prepared.
- The complex effectively catalyzed H2O2 to produce •OH through a Fenton-like reaction.
- The biotinylated complex demonstrated tumor-targeting capabilities.
- The agent showed effectiveness in tumor-targeted chemodynamic therapy.
Conclusions:
- The developed biotinylated Cu(i) complex is a potent agent for tumor-targeted chemodynamic therapy.
- The complex's ability to generate •OH from tumor-specific H2O2 highlights its therapeutic potential.
- This approach offers a novel strategy for enhancing cancer treatment efficacy.

